Palisade Bio (PALI) Cash from Operations (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.73% |
| Dec 31, 2025 | 11.51% |
| Sep 30, 2025 | -95.54% |
| Jun 30, 2025 | 22.12% |
| Mar 31, 2025 | 2.02% |
| Dec 31, 2024 | 24.00% |
| Sep 30, 2024 | 10.46% |
| Jun 30, 2024 | -10.03% |
| Mar 31, 2024 | -15.80% |
| Dec 31, 2023 | -3.16% |
| Sep 30, 2023 | -21.06% |
| Jun 30, 2023 | 37.63% |
| Mar 31, 2023 | -6.65% |
| Dec 31, 2022 | -8.75% |
| Sep 30, 2022 | 6.46% |
| Jun 30, 2022 | 13.66% |
| Mar 31, 2022 | -23.21% |
| Dec 31, 2021 | -11.25% |
| Sep 30, 2021 | 64.44% |
| Jun 30, 2021 | -517.76% |
| Mar 31, 2021 | 19.25% |
| Dec 31, 2020 | -78.14% |
| Sep 30, 2020 | -29.05% |
| Jun 30, 2020 | 59.86% |
| Mar 31, 2020 | 18.12% |
| Dec 31, 2019 | -8.00% |
| Sep 30, 2019 | -15.43% |
| Jun 30, 2019 | 1.34% |
| Mar 31, 2019 | -0.47% |
| Dec 31, 2018 | 0.36% |
| Sep 30, 2018 | 34.06% |
| Jun 30, 2018 | -36.63% |
| Mar 31, 2018 | 19.21% |
| Dec 31, 2017 | 31.20% |
| Sep 30, 2017 | 1.44% |
| Jun 30, 2017 | 24.00% |
| Mar 31, 2017 | -8.72% |
| Dec 31, 2016 | 8.84% |
| Sep 30, 2016 | -25.31% |
| Jun 30, 2016 | -2.39% |
| Mar 31, 2016 | 10.54% |
| Dec 31, 2015 | 29.21% |
| Sep 30, 2015 | -14.65% |
| Jun 30, 2015 | -1.79% |
| Mar 31, 2015 | -35.61% |
| Dec 31, 2014 | -12.22% |
| Sep 30, 2014 | -28.58% |
| Jun 30, 2014 | 11.09% |
| Mar 31, 2014 | -9.57% |
| Dec 31, 2013 | -10.37% |
| Sep 30, 2013 | 33.22% |
| Jun 30, 2013 | -33.70% |
| Mar 31, 2013 | 0.22% |
| Dec 31, 2012 | -77.32% |
| Sep 30, 2012 | 41.77% |
| Jun 30, 2012 | -16.09% |
| Mar 31, 2012 | -17.84% |
| Dec 31, 2011 | 1.72% |
| Sep 30, 2011 | 17.98% |
| Jun 30, 2011 | 3.36% |
| Mar 31, 2011 | 16.77% |
| Dec 31, 2010 | -16.86% |